PriceTargets.com logo

Greenbrook TMS - GBOKF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 03/15/2021 09:45 PM ET
+0 (0.00%)

This chart shows the closing price for GBOKF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Greenbrook TMS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GBOKF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GBOKF

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Greenbrook TMS in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for GBOKF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Greenbrook TMS. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/27/2021Stifel NicolausBoost TargetBuy$3.50 ➝ $4.00
12/16/2020Clarus SecuritiesBoost TargetBuy$3.50 ➝ $5.50
11/12/2020Stifel NicolausBoost TargetBuy$3.00 ➝ $3.10
8/5/2020Stifel NicolausInitiated CoverageBuy$3.00
5/25/2020Clarus SecuritiesReiterated RatingBuy$3.50
5/22/2020Stifel NicolausReiterated RatingBuy$3.00
(Data available from 4/18/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2023
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/20/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/18/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/19/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/18/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Greenbrook TMS logo
Greenbrook TMS Inc., together with its subsidiaries, operates a network of outpatient mental health services centers in the United States. It offers transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy that provides electromagnetic stimulation to brain regions associated with mood regulation for the treatment of major depressive disorder and other mental health disorders. The company operates approximately 121 treatment centers in the United States. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $15.45
Low: $15.45
High: $15.45

52 Week Range

Now: N/A

Volume

100 shs

Average Volume

1,572 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Greenbrook TMS?

The following Wall Street research analysts have issued reports on Greenbrook TMS in the last twelve months:
View the latest analyst ratings for GBOKF.

What is the current price target for Greenbrook TMS?

0 Wall Street analysts have set twelve-month price targets for Greenbrook TMS in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Greenbrook TMS in the next year.
View the latest price targets for GBOKF.

What is the current consensus analyst rating for Greenbrook TMS?

Greenbrook TMS currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for GBOKF.

What other companies compete with Greenbrook TMS?

Other companies that are similar to Greenbrook TMS include American Oncology Network, American Oncology Network, Bangkok Dusit Medical Services Public, Bumrungrad Hospital Public and CareRx. Learn More about companies similar to Greenbrook TMS.

How do I contact Greenbrook TMS's investor relations team?

The company's listed phone number is 416-322-9700. The official website for Greenbrook TMS is www.greenbrooktms.com. Learn More about contacing Greenbrook TMS investor relations.